Reposted by Amy Legg
👏CRE RESPOND is thrilled to announce the Sepsis: What is the Latest Data for Optimal Management of Sepsis
seminar!👏
🗓️When: Thursday 16 October, 12pm-1pm (AEST)
🗺️Where: UQCCR (or online!)
REGISTER HERE: bit.ly/3VBLeSx
Don't miss out on the chance to hear from expert clinicians and researchers!
seminar!👏
🗓️When: Thursday 16 October, 12pm-1pm (AEST)
🗺️Where: UQCCR (or online!)
REGISTER HERE: bit.ly/3VBLeSx
Don't miss out on the chance to hear from expert clinicians and researchers!
September 19, 2025 at 1:24 AM
👏CRE RESPOND is thrilled to announce the Sepsis: What is the Latest Data for Optimal Management of Sepsis
seminar!👏
🗓️When: Thursday 16 October, 12pm-1pm (AEST)
🗺️Where: UQCCR (or online!)
REGISTER HERE: bit.ly/3VBLeSx
Don't miss out on the chance to hear from expert clinicians and researchers!
seminar!👏
🗓️When: Thursday 16 October, 12pm-1pm (AEST)
🗺️Where: UQCCR (or online!)
REGISTER HERE: bit.ly/3VBLeSx
Don't miss out on the chance to hear from expert clinicians and researchers!
Reposted by Amy Legg
The whole team at CRE RESPOND are very proud of our very own Amy Legg on her graduation!
Congratulations Amy!! 👏🎉
@leggwamy.bsky.social
Congratulations Amy!! 👏🎉
@leggwamy.bsky.social
Graduation nation! Huge thanks to the supers @gurujosh.bsky.social @steventong.bsky.social Jane Davies, Jason Roberts. Look after your kidneys guys!
September 19, 2025 at 1:31 AM
The whole team at CRE RESPOND are very proud of our very own Amy Legg on her graduation!
Congratulations Amy!! 👏🎉
@leggwamy.bsky.social
Congratulations Amy!! 👏🎉
@leggwamy.bsky.social
Graduation nation! Huge thanks to the supers @gurujosh.bsky.social @steventong.bsky.social Jane Davies, Jason Roberts. Look after your kidneys guys!
September 17, 2025 at 4:57 AM
Graduation nation! Huge thanks to the supers @gurujosh.bsky.social @steventong.bsky.social Jane Davies, Jason Roberts. Look after your kidneys guys!
Reposted by Amy Legg
🤩Dr Andrew Burke's recent presentation on 'Therapeutic Drug Monitoring in Non-Tuberculous Mycobacteria' was not one to miss...
📢Luckily, even if you weren't able to attend the Respiratory Infections seminar, you won't have to!
youtu.be/V2nITG_rxp8?...
📢Luckily, even if you weren't able to attend the Respiratory Infections seminar, you won't have to!
youtu.be/V2nITG_rxp8?...
03 Dr Andrew Burke - Therapeutic Drug Monitoring in Non-Tuberculous Mycobacteria
YouTube video by cre.respond
youtu.be
September 17, 2025 at 1:42 AM
🤩Dr Andrew Burke's recent presentation on 'Therapeutic Drug Monitoring in Non-Tuberculous Mycobacteria' was not one to miss...
📢Luckily, even if you weren't able to attend the Respiratory Infections seminar, you won't have to!
youtu.be/V2nITG_rxp8?...
📢Luckily, even if you weren't able to attend the Respiratory Infections seminar, you won't have to!
youtu.be/V2nITG_rxp8?...
Reposted by Amy Legg
Congratulations Elise Mitri from NACE, Austin Health & The Peter Doherty Institute presenting the iNAAN Trial results - > 5000 pts & 1500 inpatient #penicillinallergy DOC performed. Safe irrespective of stakeholder with significant prescribing gains. Largest inpatient penicillin allergy study 👏🎉
August 29, 2025 at 8:17 AM
Congratulations Elise Mitri from NACE, Austin Health & The Peter Doherty Institute presenting the iNAAN Trial results - > 5000 pts & 1500 inpatient #penicillinallergy DOC performed. Safe irrespective of stakeholder with significant prescribing gains. Largest inpatient penicillin allergy study 👏🎉
Reposted by Amy Legg
On 7 August 2025, we will be hosting our Worldwide Precision Dosing seminar for the fifth year!💉
📢Chaired by Dr Amy Legg, a clinical pharmacist at RBWH, this event explores individualised drug therapy.
To find out more about this event and register: bit.ly/3GtrIUb
@leggwamy.bsky.social
#UQCCR
📢Chaired by Dr Amy Legg, a clinical pharmacist at RBWH, this event explores individualised drug therapy.
To find out more about this event and register: bit.ly/3GtrIUb
@leggwamy.bsky.social
#UQCCR
July 18, 2025 at 2:27 AM
On 7 August 2025, we will be hosting our Worldwide Precision Dosing seminar for the fifth year!💉
📢Chaired by Dr Amy Legg, a clinical pharmacist at RBWH, this event explores individualised drug therapy.
To find out more about this event and register: bit.ly/3GtrIUb
@leggwamy.bsky.social
#UQCCR
📢Chaired by Dr Amy Legg, a clinical pharmacist at RBWH, this event explores individualised drug therapy.
To find out more about this event and register: bit.ly/3GtrIUb
@leggwamy.bsky.social
#UQCCR
Always happy to celebrate you @minyonavent.bsky.social ❤️ what a packet of legends
To celebrate #IDPharmacistsDay look out for the videos from AdPha.au pharmacists showcasing their contributions to Innovations in Infectious Diseases @adphaau.bsky.social @nadinehillock.bsky.social @sonkoning.bsky.social @leggwamy.bsky.social @sidpharm.bsky.social
May 22, 2025 at 12:07 AM
Always happy to celebrate you @minyonavent.bsky.social ❤️ what a packet of legends
Reposted by Amy Legg
✨Hello and welcome to the official CRE Respond page!✨
CRE RESPOND aims to reduce the burden of antimicrobial resistance through optimal personalised dosing. 💊
🚨Follow us to stay up to date with our educational events and the latest goings-on in the world of anti-microbial optimisation!
#uqccr
CRE RESPOND aims to reduce the burden of antimicrobial resistance through optimal personalised dosing. 💊
🚨Follow us to stay up to date with our educational events and the latest goings-on in the world of anti-microbial optimisation!
#uqccr
May 21, 2025 at 11:51 PM
✨Hello and welcome to the official CRE Respond page!✨
CRE RESPOND aims to reduce the burden of antimicrobial resistance through optimal personalised dosing. 💊
🚨Follow us to stay up to date with our educational events and the latest goings-on in the world of anti-microbial optimisation!
#uqccr
CRE RESPOND aims to reduce the burden of antimicrobial resistance through optimal personalised dosing. 💊
🚨Follow us to stay up to date with our educational events and the latest goings-on in the world of anti-microbial optimisation!
#uqccr
Reposted by Amy Legg
Congrats to @elisemitri.bsky.social, @trubianojason.bsky.social et al for their great work on safely delabeling patients with #penicillinallergy. Elise presenting their prospective, pharmacist-led program live at #ESCMIDGlobal
#IDSky #PharmSky #openacess
www.cmi-comms.com/article/S295...
#IDSky #PharmSky #openacess
www.cmi-comms.com/article/S295...
April 13, 2025 at 12:09 PM
Congrats to @elisemitri.bsky.social, @trubianojason.bsky.social et al for their great work on safely delabeling patients with #penicillinallergy. Elise presenting their prospective, pharmacist-led program live at #ESCMIDGlobal
#IDSky #PharmSky #openacess
www.cmi-comms.com/article/S295...
#IDSky #PharmSky #openacess
www.cmi-comms.com/article/S295...
Reposted by Amy Legg
#SNAPtrial will answer this question in a large RCT (rather than observational). Come to ESCMID global and hear the results!
February 13, 2025 at 8:20 PM
#SNAPtrial will answer this question in a large RCT (rather than observational). Come to ESCMID global and hear the results!
Reposted by Amy Legg
Approaching more than all previous SAB trials combined! What next?!
Haven't posted about SNAP for a while:
But we've just hit 4000 participants. Almost at 3 years since opening.
And submitting two late breaker oral abstracts to ESCMID Global. @escmid.bsky.social
Amazing progress and more to come.
@gurujosh.bsky.social @drtoddlee.bsky.social
But we've just hit 4000 participants. Almost at 3 years since opening.
And submitting two late breaker oral abstracts to ESCMID Global. @escmid.bsky.social
Amazing progress and more to come.
@gurujosh.bsky.social @drtoddlee.bsky.social
February 9, 2025 at 10:29 AM
Approaching more than all previous SAB trials combined! What next?!
Interested in PK modelling? CRE RESPOND is running its Population Pharmacokinetics workshop, from fundamentals to clinical practice. Much more practical program this year! Be quick spaces are limited.
Register here: bit.ly/3ElRmJ6
Register here: bit.ly/3ElRmJ6
Population pharmacokinetics: from fundamentals to clinical practice
Are you looking to enhance your knowledge of pharmacokinetics (PK) and gain hands-on experience with population pharmacokinetic (popPK) modelling? Whether you are new to the field or looking to deepen...
bit.ly
February 5, 2025 at 12:46 AM
Interested in PK modelling? CRE RESPOND is running its Population Pharmacokinetics workshop, from fundamentals to clinical practice. Much more practical program this year! Be quick spaces are limited.
Register here: bit.ly/3ElRmJ6
Register here: bit.ly/3ElRmJ6
Really excited by this article from @idpharmacometrx.bsky.social et al. Protamine as the prototype for megalin blockade to reduce/delay kidney accumulation of vanc (and maybe colistin and aminoglycosides…). But also an excellent VIKI overview, fab pics 💕
journals.asm.org/doi/10.1128/...
journals.asm.org/doi/10.1128/...
Protamine protects against vancomycin-induced kidney injury | Antimicrobial Agents and Chemotherapy
Vancomycin is one of the most widely used antibiotics within United States in-patient
healthcare systems, accounting for 11.9% of all antibiotic use for inpatient antimicrobials
(1,258 out of 10,612) ...
journals.asm.org
January 23, 2025 at 12:34 AM
Really excited by this article from @idpharmacometrx.bsky.social et al. Protamine as the prototype for megalin blockade to reduce/delay kidney accumulation of vanc (and maybe colistin and aminoglycosides…). But also an excellent VIKI overview, fab pics 💕
journals.asm.org/doi/10.1128/...
journals.asm.org/doi/10.1128/...
I learnt to name studies from the best!
Awesome work (and title) by star PhD student Amy Legg. How common is AKI in patients with SAB? We looked in this big cohort to find out…..
🆕💫Retrospective cohort study #CMI
AKI is a frequent complication of S. aureus bacteraemia and is associated with 30-day mortality
Not “a cute” complication: phenotypic analysis of acute kidney injury in S. aureus bacteraemia #idsky #EMIMCC
www.clinicalmicrobiologyandinfection.com/article/S119...
AKI is a frequent complication of S. aureus bacteraemia and is associated with 30-day mortality
Not “a cute” complication: phenotypic analysis of acute kidney injury in S. aureus bacteraemia #idsky #EMIMCC
www.clinicalmicrobiologyandinfection.com/article/S119...
January 12, 2025 at 11:56 PM
I learnt to name studies from the best!
Reposted by Amy Legg
🆕💫Retrospective cohort study #CMI
AKI is a frequent complication of S. aureus bacteraemia and is associated with 30-day mortality
Not “a cute” complication: phenotypic analysis of acute kidney injury in S. aureus bacteraemia #idsky #EMIMCC
www.clinicalmicrobiologyandinfection.com/article/S119...
AKI is a frequent complication of S. aureus bacteraemia and is associated with 30-day mortality
Not “a cute” complication: phenotypic analysis of acute kidney injury in S. aureus bacteraemia #idsky #EMIMCC
www.clinicalmicrobiologyandinfection.com/article/S119...
DEFINE_ME
www.clinicalmicrobiologyandinfection.com
December 31, 2024 at 4:37 AM
🆕💫Retrospective cohort study #CMI
AKI is a frequent complication of S. aureus bacteraemia and is associated with 30-day mortality
Not “a cute” complication: phenotypic analysis of acute kidney injury in S. aureus bacteraemia #idsky #EMIMCC
www.clinicalmicrobiologyandinfection.com/article/S119...
AKI is a frequent complication of S. aureus bacteraemia and is associated with 30-day mortality
Not “a cute” complication: phenotypic analysis of acute kidney injury in S. aureus bacteraemia #idsky #EMIMCC
www.clinicalmicrobiologyandinfection.com/article/S119...
Reposted by Amy Legg
**Starting 2025 with a key update:
The new ATS/CDC/ERS/IDSA guidelines on treating drug-susceptible and drug-resistant tuberculosis (TB) are out!
What do you think about these changes? How will they shape clinical practice moving forward?**
#idsky #tbsky #EMIMCC
🆕🔥Just published 🔥🆕
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis(TB)
An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline #idsky #TBsky
www.atsjournals.org/doi/full/10....
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis(TB)
An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline #idsky #TBsky
www.atsjournals.org/doi/full/10....
January 2, 2025 at 7:10 PM
Reposted by Amy Legg
Pharmacodynamic studies indicate that anaerobic killing is optimized when the plasma AUC) to MIC ratio is ≥70:1; the probability of achieving this target with 1000mg/d of metronidazole is > 99% against B. fragilis that exhibit MICs < 2mg/L #idsky #medsky #EMIMCC
🆕️✨️The largest study to date of patients with Bacteroides spp. bacteremia
Metronidazole 500mg q12h dosing was not associated with worse outcomes compared to metronidazole 500mgq8h
Metro:500mgq12h must be used for most types of infections #idsky #medsky #EMIMCC
www.sciencedirect.com/science/arti...
Metronidazole 500mg q12h dosing was not associated with worse outcomes compared to metronidazole 500mgq8h
Metro:500mgq12h must be used for most types of infections #idsky #medsky #EMIMCC
www.sciencedirect.com/science/arti...
Clinical outcomes of a twice daily metronidazole dosing strategy for Bacteroides bloodstream infections
The optimal metronidazole dose for the treatment of Bacteroides spp. has not been well-defined.This study was a multicenter, retrospective chart revie…
www.sciencedirect.com
December 10, 2024 at 8:14 PM
Reposted by Amy Legg
🆕🔥Retrospective, multicenter, inverse probability-of-treatment weighted cohort study
Among hospitalized patients with septic shock, there was no difference between cefepime and piperacillin-tazobactam on the occurrence of severe AKI #idsky #medsky
academic.oup.com/cid/advance-...
Among hospitalized patients with septic shock, there was no difference between cefepime and piperacillin-tazobactam on the occurrence of severe AKI #idsky #medsky
academic.oup.com/cid/advance-...
December 5, 2024 at 8:28 PM
🆕🔥Retrospective, multicenter, inverse probability-of-treatment weighted cohort study
Among hospitalized patients with septic shock, there was no difference between cefepime and piperacillin-tazobactam on the occurrence of severe AKI #idsky #medsky
academic.oup.com/cid/advance-...
Among hospitalized patients with septic shock, there was no difference between cefepime and piperacillin-tazobactam on the occurrence of severe AKI #idsky #medsky
academic.oup.com/cid/advance-...
Just in case you missed it Dr Emily Heil and Dr Julie Ann Justo with the greatest overview of aminoglycoside dosing for #UQCCR earlier this year! All the recordings here cre-respond.centre.uq.edu.au/event/sessio...
Worldwide Precision Dosing Seminar
CRE RESPOND's fourth Annual Worldwide Precision Dosing seminar was held on Tuesday 10 September. Our panel of expert clinicians and clinical educators, from America, Europe and Australia, covered whe...
cre-respond.centre.uq.edu.au
December 5, 2024 at 10:42 PM
Just in case you missed it Dr Emily Heil and Dr Julie Ann Justo with the greatest overview of aminoglycoside dosing for #UQCCR earlier this year! All the recordings here cre-respond.centre.uq.edu.au/event/sessio...